A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline.

Autor: Shanmugalingam R; Liverpool Hospital, Sydney, NSW.; Western Sydney University, Sydney, NSW., Barrett HL; Royal Hospital for Women, Sydney, NSW.; University of New South Wales, Sydney, NSW., Beech A; Royal Hospital for Women, Sydney, NSW.; University of New South Wales, Sydney, NSW., Bowyer L; Royal Hospital for Women, Sydney, NSW., Crozier T; Monash Medical Centre, Melbourne, VIC.; Monash University, Melbourne, VIC., Davidson A; Australian Pregnancy Hypertension Foundation Limited, Sydney, NSW., Dekker Nitert M; University of Queensland, Brisbane, QLD., Doyle K; Western Sydney University, Sydney, NSW., Grzeskowiak L; Flinders Medical Centre, Flinders University, Adelaide, SA., Hall N; Liverpool Hospital, Sydney, NSW., Cheikh Hassan HI; Illawarra Shoalhaven Local Health District, Wollongong, NSW.; University of Wollongong, Wollongong, NSW., Hennessy A; Western Sydney University, Sydney, NSW.; Campbelltown Hospital, Sydney, NSW., Henry A; University of New South Wales, Sydney, NSW.; St George Hospital, Sydney, NSW., Langsford D; Grampians Health, Ballarat, VIC.; University of Melbourne, Ballarat, VIC., Lee VW; University of Sydney, Sydney, NSW.; Westmead Hospital, Sydney, NSW., Munn Z; Health Evidence Synthesis, Recommendations and Impact (HESRI), University of Adelaide, Adelaide, SA., Peek MJ; Australian National University, Canberra, ACT.; Centenary Hospital for Women and Children, Canberra, ACT., Said JM; University of Melbourne, Ballarat, VIC.; Joan Kirner Women's and Children's Sunshine Hospital, Melbourne, VIC., Tanner H; Royal Brisbane and Women's Hospital, Brisbane, QLD., Taylor R; Waikato Women's Hospital, Hamilton, New Zealand., Ward M; Royal Hospital for Women, Sydney, NSW., Waugh J; University of Auckland, Auckland, New Zealand., Yen LL; Te Whatu Ora - Health New Zealand Counties Manukau, Auckland, New Zealand., Medcalf E; University of Sydney, Sydney, NSW., Bell KJ; University of Sydney, Sydney, NSW., Ackermann D; University of Sydney, Sydney, NSW., Turner R; Biostatistics Centre, University of Otago, Dunedin, New Zealand., Makris A; Liverpool Hospital, Sydney, NSW.; Western Sydney University, Sydney, NSW.
Jazyk: angličtina
Zdroj: The Medical journal of Australia [Med J Aust] 2024 Jun 17; Vol. 220 (11), pp. 582-591. Date of Electronic Publication: 2024 May 19.
DOI: 10.5694/mja2.52312
Abstrakt: Introduction: Hypertensive disorders of pregnancy (HDP) affect up to 10% of all pregnancies annually and are associated with an increased risk of maternal and fetal morbidity and mortality. This guideline represents an update of the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) guidelines for the management of hypertensive disorders of pregnancy 2014 and has been approved by the National Health and Medical Research Council (NHMRC) under section 14A of the National Health and Medical Research Council Act 1992. In approving the guideline recommendations, NHMRC considers that the guideline meets NHMRC's standard for clinical practice guidelines.
Main Recommendations: A total of 39 recommendations on screening, preventing, diagnosing and managing HDP, especially preeclampsia, are presented in this guideline. Recommendations are presented as either evidence-based recommendations or practice points. Evidence-based recommendations are presented with the strength of recommendation and quality of evidence. Practice points were generated where there was inadequate evidence to develop specific recommendations and are based on the expertise of the working group.
Changes in Management Resulting From the Guideline: This version of the SOMANZ guideline was developed in an academically robust and rigorous manner and includes recommendations on the use of combined first trimester screening to identify women at risk of developing preeclampsia, 14 pharmacological and two non-pharmacological preventive interventions, clinical use of angiogenic biomarkers and the long term care of women who experience HDP. The guideline also includes six multilingual patient infographics which can be accessed through the main website of the guideline. All measures were taken to ensure that this guideline is applicable and relevant to clinicians and multicultural women in regional and metropolitan settings in Australia and New Zealand.
(© 2024 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.)
Databáze: MEDLINE
Externí odkaz: